GOVX

Conviction 12HealthcareScan · Mon, Aug 10, 2026

GOVX$0.7721+0.29%

ResistanceSupportVol 14

Vol MA14 159.09K

May 11May 28Jun 16Jul 6Jul 23Aug 10

GeoVax Labs, Inc.PHARMACEUTICAL PREPARATIONSwww.geovax.com ↗

Price0.7721

Change+0.29%

Gap+2.96%

Rel volume0.57×

Avg volume212.29K

Avg $ vol180.12K

SMA 200.8226

SMA 501.16

SMA 2001.29

Price vs 50-33.51%

Price vs 200-40.11%

MA stackbearish

50/200 crossdeath · 2d

Supertrenddown · 1.03

RSI (14)38

MACD hist0.02

MACD crossbull · 4d

Stoch %K / %D35 / 30

ADX (14)28

+DI / −DI15 / 26

RSI divergence—

MACD divergenceBullish

ATR %+13.45%

ADR %11.18%

52w high3.64

52w low0.1592

From 52w high-78.79%

Above 52w low+384.99%

New 52w highNo

SqueezeOff

Bollinger width58.36%

%B0.39

Donchian pos27.70%

Donchian high1.12

Donchian low0.6388

AVWAP (52w high)2.76

vs AVWAP high-71.98%

AVWAP (52w low)2.23

vs AVWAP low-65.39%

OBV trendDown

Chaikin MF (20)-0.24

Today vs 20d0.57×

Avg vol (14d)159.09K

Avg vol (20d)212.29K

Avg $ vol (20d)180.12K

Market cap—

RS 3m (vs SPY)-61.95%

RS 6m (vs SPY)-84.27%

RS line new highNo

Trend template3/8

Technical rank8.0

1 week+6.54%

1 month-34.57%

3 months-53.77%

6 months-71.08%

1 year+15.34%

YTD+273.00%

P/E-0.26

P/B3.22

P/S2.28

P/FCF-0.26

EPS-3.04

Div yield—

ROE—

ROA-462.33%

Debt/Eq—

Current1.54

EV/EBITDA-0.12

Gross margin—

Net margin-862.34%

Rev growth-37.06%

EPS growth14.11%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value2.53M

Revenue0

Net income-4.43M

Gross profit—

Free cash flow-21.5M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out5.21M

Employees19

ListedWed, Feb 1, 1995

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction12 / 100

Pattern quality—

Tech rank8.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.43

Support0.7309

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in GOVX

All disclosures →

No recent disclosed trades by Congress in GOVX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GOVX · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Morgan Jayne Director · Stock Option · 2026-06-17	Grant	6K	—	2026-06-17	2026-06-22
SPENCER JOHN N JR Director · Stock Option · 2026-06-17	Grant	6K	—	2026-06-17	2026-06-22
Kollintzas Dean G Director · Stock Option · 2026-06-17	Grant	6K	—	2026-06-17	2026-06-22
Lemerond Nicole Director · Stock Option · 2026-06-17	Grant	6K	—	2026-06-17	2026-06-22
CHASE RANDAL D Director · Stock Option · 2026-06-17	Grant	6K	—	2026-06-17	2026-06-22
McKee Kelly T. Jr. Chief Medical Officer · Stock Option · 2026-06-17	Grant	17.6K	—	2026-06-17	2026-06-22
NEWMAN MARK J Chief Scientific Officer · Stock Option · 2026-06-17	Grant	17.6K	—	2026-06-17	2026-06-22
Reynolds Mark CFO · Stock Option · 2026-06-17	Grant	17.6K	—	2026-06-17	2026-06-22
MCNALLY ROBERT T Director · Stock Option · 2026-06-17	Grant	6K	—	2026-06-17	2026-06-22
DODD DAVID A President, CEO · Stock Option · 2026-06-17	Grant	29.3K	—	2026-06-17	2026-06-22

SEC filings

EDGAR filings in GOVX · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.